Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M O Coupe

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 1, 1989
Calcitonin gene-related peptide vasodilation of human pulmonary vesselsD G McCormack, J C Mak, M O Coupe, et al.
European Journal of Clinical Pharmacology|January 1, 1988
The cardiovascular effects of nebulized adenosine in manM O Coupe, B Clarke, A Robson, et al.
Lancet (London, England)|January 28, 1989
Adenosine and hypertrophic cardiomyopathyM O Coupe, B Clarke, E Rowland, et al.
Circulation|March 1, 1990
Autoradiographic mapping of calcitonin gene-related peptide receptors in human and guinea pig heartsM O Coupe, J C Mak, M Yacoub, et al.
British Medical Journal (Clinical Research Ed.)|May 2, 1987
Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonistJ V Anderson, M O Coupe, J A Morris, et al.
International Journal of Clinical Practice|May 27, 1999
Is a man's facial appearance predictive of how he will die?D Cummins, P Hoskin, J Young, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1988
The effects of the 5-hydroxytryptamine (5HT3) receptor antagonist ICS 205-930 in the carcinoid syndromeM O Coupe, J V Anderson, J A Morris, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 1, 1989
Calcitonin gene-related peptide vasodilation of human pulmonary vesselsD G McCormack, J C Mak, M O Coupe, et al.
European Journal of Clinical Pharmacology|January 1, 1988
The cardiovascular effects of nebulized adenosine in manM O Coupe, B Clarke, A Robson, et al.
Lancet (London, England)|January 28, 1989
Adenosine and hypertrophic cardiomyopathyM O Coupe, B Clarke, E Rowland, et al.
Circulation|March 1, 1990
Autoradiographic mapping of calcitonin gene-related peptide receptors in human and guinea pig heartsM O Coupe, J C Mak, M Yacoub, et al.
British Medical Journal (Clinical Research Ed.)|May 2, 1987
Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonistJ V Anderson, M O Coupe, J A Morris, et al.
International Journal of Clinical Practice|May 27, 1999
Is a man's facial appearance predictive of how he will die?D Cummins, P Hoskin, J Young, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1988
The effects of the 5-hydroxytryptamine (5HT3) receptor antagonist ICS 205-930 in the carcinoid syndromeM O Coupe, J V Anderson, J A Morris, et al.
Pageof 2